Cargando…

FcγRII (CD32) modulates antibody clearance in NOD SCID mice leading to impaired antibody-mediated tumor cell deletion

BACKGROUND: Immune compromised mice are increasingly used for the preclinical development of monoclonal antibodies (mAb). Most common are non-obese diabetic (NOD) severe combined immunodeficient (SCID) and their derivatives such as NOD SCID interleukin-2 γ-/- (NSG), which are attractive hosts for pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oldham, Robert J, Mockridge, C Ian, James, Sonya, Duriez, Patrick J, Chan, H T Claude, Cox, Kerry L, Pitic, Vicentiu A, Glennie, Martin J, Cragg, Mark S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Basic Tumor Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304853/ https://www.ncbi.nlm.nih.gov/pubmed/32554613 http://dx.doi.org/10.1136/jitc-2020-000619

Ejemplares similares

Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments
por: Moreno-Vicente, Julia, et al.
Publicado: (2022)

The Human FcγRII (CD32) Family of Leukocyte FcR in Health and Disease
por: Anania, Jessica C., et al.
Publicado: (2019)

FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms
por: Simpson, Alexander P., et al.
Publicado: (2022)

Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment
por: Liu, Rena, et al.
Publicado: (2020)

FcγRII-binding Centyrins mediate agonism and antibody-dependent cellular phagocytosis when fused to an anti-OX40 antibody
por: Zhang, Di, et al.
Publicado: (2018)

Measles Virus Nucleocapsid Protein Binds to FcγRII and Inhibits Human B Cell Antibody Production
por: Ravanel, Kissia, et al.
Publicado: (1997)

Differential Secondary Reconstitution of In Vivo-Selected Human SCID-Repopulating Cells in NOD/SCID versus NOD/SCID/γ chain(null) Mice
por: Cai, Shanbao, et al.
Publicado: (2011)

Regulation of Monoclonal Antibody Immunotherapy by FcγRIIB
por: Stopforth, Richard J., et al.
Publicado: (2016)

Expression and function of FcγRII on NK cells in rhesus macaques
por: He, X, et al.
Publicado: (2012)

Decreased expression of FcγRII in active Graves' disease patients
por: Lu, Xixuan, et al.
Publicado: (2019)

Plasmapheresis, Anti-ACE2 and Anti-FcγRII Monoclonal Antibodies: A Possible Treatment for Severe Cases of COVID-19
por: Sedokani, Amin, et al.
Publicado: (2020)

Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes
Publicado: (1989)

The inhibitory receptor FcγRII reduces joint inflammation in immune complex arthritis not only by inhibition of activatory FcγR but also by efficient clearance of immune complexes
por: van Lent, PL, et al.
Publicado: (2003)

Fcγ receptor binding is required for maximal immunostimulation by CD70-Fc
por: Dadas, Osman, et al.
Publicado: (2023)

Anti-CD7 antibody and immunotoxin treatment of human CD7(+)T-cell leukaemia is significantly less effective in NOD/LtSz-scid mice than in CB.17 scid mice
por: Flavell, D J, et al.
Publicado: (2000)

Immunoglobulin-Like Transcript 3-Fc Suppresses T-Cell Responses to Allogeneic Human Islet Transplants in hu-NOD/SCID Mice
por: Vlad, George, et al.
Publicado: (2008)

Targeted Fcγ Receptor (FcγR)-mediated Clearance by a Biparatopic Bispecific Antibody
por: Kasturirangan, Srinath, et al.
Publicado: (2017)

Agonistic CD27 antibody potency is determined by epitope-dependent receptor clustering augmented through Fc-engineering
por: Heckel, Franziska, et al.
Publicado: (2022)

The intraspleen huPBL NOD/SCID model to study the human HIV-specific antibody response selected in the course of natural infection
por: Steyaert, Sophia, et al.
Publicado: (2007)

HIF activation enhances FcγRIIb expression on mononuclear phagocytes impeding tumor targeting antibody immunotherapy
por: Hussain, Khiyam, et al.
Publicado: (2022)

Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells
por: Cragg, M S, et al.
Publicado: (1999)

Reevaluation of NOD/SCID Mice as NK Cell-Deficient Models
por: Miao, Miao, et al.
Publicado: (2021)

Complex Interplay between Epitope Specificity and Isotype Dictates the Biological Activity of Anti-human CD40 Antibodies
por: Yu, Xiaojie, et al.
Publicado: (2018)

Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking
por: Turaj, Anna H., et al.
Publicado: (2018)

Expression of the Fc-receptor for IgE (Fc epsilon RII, CD23) on alveolar macrophages in extrinsic allergic alveolitis
Publicado: (1990)

Recombinant soluble human Fc gamma RII: production, characterization, and inhibition of the Arthus reaction
Publicado: (1993)

Fcγ Receptor-Mediated Inflammation Inhibits Axon Regeneration
por: Zhang, Gang, et al.
Publicado: (2014)

Differential Post-Surgical Metastasis and Survival in SCID, NOD-SCID and NOD-SCID-IL-2Rγ(null) Mice with Parental and Subline Variants of Human Breast Cancer: Implications for Host Defense Mechanisms Regulating Metastasis
por: Milsom, Chloe C., et al.
Publicado: (2013)

Identification of the low affinity receptor for immunoglobulin E on mouse mast cells and macrophages as Fc gamma RII and Fc gamma RIII
Publicado: (1992)

The glycosyl phosphatidylinositol-linked FcγRIII(PMN) mediates transmembrane signaling events distinct from FcγRII
por: Kimberly, RP, et al.
Publicado: (1990)

Spiny mice (Acomys) cells fail to engraft in NOD scid gamma
por: Gaire, Janak, et al.
Publicado: (2023)

Reference genomes for BALB/c Nude and NOD/SCID mouse models
por: Schmid-Siegert, Emanuel, et al.
Publicado: (2023)

Studies on the role of interleukin-4 and Fc epsilon RII in the pathogenesis of minimal change nephrotic syndrome.
por: Cho, B. S., et al.
Publicado: (1992)

Surface-bound immune complexes containing antibodies to collagen type II induce production of TNF-α, IL-1β and IL-8 from monocytes via FcγRII
por: Mullazehi, M, et al.
Publicado: (2004)

Comparison of biological features between severely immuno-deficient NOD/Shi-scid Il2rg(null) and NOD/LtSz-scid Il2rg(null) mice
por: Nagatani, Mariko, et al.
Publicado: (2019)

A radiolabeled antibody targeting CD123(+) leukemia stem cells – initial radioimmunotherapy studies in NOD/SCID mice engrafted with primary human AML
por: Leyton, Jeffrey V., et al.
Publicado: (2015)

Maternal antibodies facilitate Amyloid-β clearance by activating Fc-receptor-Syk-mediated phagocytosis
por: Illouz, Tomer, et al.
Publicado: (2021)

Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII-dependent entry into B cells in vitro
por: Kam, Yiu Wing, et al.
Publicado: (2007)

In vivo Effects of a Histone Deacetylase Inhibitor, FK228, on Human Acute Promyelocytic Leukemia in NOD/Shi‐scid/scid Mice
por: Kosugi, Hiroshi, et al.
Publicado: (2001)

Chemically-Modified Tetraiodothyroacetic Acid (Tetrac) Induces Cancer Cell Apoptosis and Facilitates Clearance of Apoptotic Debris (Efferocytosis)
por: Godugu, Kavitha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cgepalcch7nk9gio9r8ant7rrf